Vistagen therapeutics further advances palisade phase 3 program for ph94b in social anxiety disorder with initiation of palisade-2

Palisade phase 3 program focused on ph94b's potential as a rapid-onset, acute treatment of anxiety in adults with social anxiety disorder palisade phase 3 program focused on ph94b's potential as a rapid-onset, acute treatment of anxiety in adults with social anxiety disorder
VTGN Ratings Summary
VTGN Quant Ranking